Alexandria Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $7.54M | Buy |
60,010
+758
| +1% | +$95.3K | 0.7% | 51 |
|
|
2021
Q2 | $8.02M | Buy |
59,252
+1,052
| +2% | +$142K | 0.74% | 49 |
|
|
2021
Q1 | $7.9M | Sell |
58,200
-859
| -1% | -$117K | 0.8% | 42 |
|
|
2020
Q4 | $8.31M | Buy |
59,059
+11,036
| +23% | +$1.55M | 0.88% | 32 |
|
|
2020
Q3 | $5.34M | Buy |
48,023
+7,499
| +19% | +$834K | 0.64% | 52 |
|
|
2020
Q2 | $4.54M | Buy |
40,524
+27,764
| +218% | +$3.11M | 0.59% | 60 |
|
|
2020
Q1 | $988K | Buy |
12,760
+1,084
| +9% | +$83.9K | 0.16% | 126 |
|
|
2019
Q4 | $1.11M | Buy |
11,676
+2,171
| +23% | +$207K | 0.15% | 131 |
|
|
2019
Q3 | $725K | Buy |
9,505
+4,350
| +84% | +$332K | 0.11% | 148 |
|
|
2019
Q2 | $452K | Buy |
+5,155
| New | +$452K | 0.06% | 190 |
|